跳至主要内容
临床试验/JPRN-jRCTs041200069
JPRN-jRCTs041200069招募中未知

Renoprotective effect of canagliflozin derived from test of renal hemodynamics in diabetic kidney disease - FAGOTTO study

Maruyama Shoichi0 个研究点目标入组 110 人开始时间: 2020年11月27日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • patients with stable type 2 diabetes
  • -eGFR(Crteatinine)<= 60mL/min/1.73m2
  • -patients who are taking renin angiotensin system inhibitors (exclude intolerable or non-adaptive)
  • -older than 18 years
  • -written consent

排除标准

  • -SGLT2 inhibitors users within 8 weeks
  • -30-under maintenance dialysis therapy or history of kidney plantation
  • -diuretics users
  • -patients who are taking both ACEi and ARB (renin inhibitor)
  • -active nephritis or kidney disease
  • -obvious steroid diabetes
  • -patients whose ALT and AST levels exceed 2.0 times the facility standard value
  • -heart failure NYHA class 4
  • -pregnant, or desiring to bear children
  • -inapporopriate for this study as judged by attending investigateor

研究者

相似试验